Black Hawk Acquisition Corporation (BKHA)
Oxford Ledge is still expanding full research coverage of BKHA. A live quote, fundamentals, and analysis are available in the app; the SEC-sourced material below is what we currently have indexed here.
Business summary
A Cayman Islands company formed to merge with or acquire target businesses, currently pursuing a combination with Vesicor Therapeutics.
SEC filings
- 8-K Entry into material agreement; Creation of direct financial obligation; 3.02; Financial statements and exhibits 2026-05-08
- 10-K/A Amended annual report 2026-04-28
- 10-Q Quarterly financial report (unaudited) 2026-04-21
- 8-K Delisting / transfer of listing 2026-04-01
- 8-K Departure/election of directors or officers; Regulation FD disclosure; Financial statements and exhibits 2026-03-17
Source: SEC EDGAR.
Insider activity
2 recent insider (SEC Form 4) filings on record for BKHA. View the transactions in the terminal.
Source: SEC EDGAR (Form 4).
- Open BKHA in the Oxford Ledge terminal — live quote, chart, and analysis in the app.
- Browse the covered-stock index
- Learn to analyze stocks yourself
The material above is drawn from public SEC EDGAR filings and is provided for educational purposes, not as investment advice. Live pricing and fundamentals are available in the terminal.